Parameter | Supplements | Placebo | Interventions |
---|
4 weeks | 8 weeks |
---|
Calcium [mg/d] | CaP | 938b (197) | 1998a (192)1
| 2014a (194)1
|
Vitamin D3
| 905 (187) | 897 (219)2
| 916 (203)2
|
CaP+vitamin D3
t
| 889b (154) | 1913a (151)1
| 1872a (164)1
|
Phosphorous [mg/d] | CaP | 1337b (250) | 1803a (247)1
| 1833a (242)1
|
Vitamin D3
| 1311 (236) | 1303 (247)2
| 1324 (226)2
|
CaP+vitamin D3
| 1286b (172) | 1733a (180)1
| 1705a (187)2
|
Vitamin D3 [μg/d] | CaP | 6.5 (0.6) | 6.6 (0.6)1
| 6.6 (0.5)1
|
Vitamin D3
| 6.2b (1.3) | 15.2a (1.0)2
| 15.2a (1.0)2
|
CaP+vitamin D3
| 6.5b (0.4) | 15.1a (0.4)2
| 15.1a (0.3)2
|
- n = 56; data are expressed as mean (standard deviation); CaP: tricalcium phosphate; a b mean values within a row with dissimilar superscript letters are significantly different (p ≤ 0.05); 1 2 mean values within a column with dissimilar superscript numbers are significantly different (p ≤ 0.05); results without superscripts in a row/column have no significant differences; effect of time was tested using general linear model with repeated measurements (with pairwise comparisons based on Fishers-LSD test); effect of supplementation was tested using univariate analysis of variance followed by Student-Newman-Keuls post hoc test.; t for statistical analysis the data were log10 transformed, because of variance heterogeneity.